Status:
COMPLETED
Study of Coffee Mannooligosaccharides for Weight Management
Lead Sponsor:
Mondelēz International, Inc.
Collaborating Sponsors:
St. Luke's-Roosevelt Hospital Center
Conditions:
Obesity
Eligibility:
All Genders
20-65 years
Phase:
NA
Brief Summary
The goal of this study is to establish the role of coffee mannooligosaccharides (MOS), provided in a beverage format, on body weight regulation. Overweight and obese men and women will be randomized t...
Eligibility Criteria
Inclusion
- Body mass index 27-33 kg/m2
- Stable body weight
Exclusion
- Body width \> 46 cm
- Medications known to affect body weight, lipids, blood pressure
- Pregnant or lactating women
- Less than 1 y post-partum
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2007
Estimated Enrollment :
82 Patients enrolled
Trial Details
Trial ID
NCT00932750
Start Date
September 1 2006
End Date
November 1 2007
Last Update
August 22 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Luke's/Roosevelt Hospital
New York, New York, United States, 10025